CeriBell, Inc. (CBLL) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About CeriBell, Inc.
CeriBell, Inc. is led by CEO Xingjuan Chao, publicly traded since 2024.
CeriBell, Inc. (CBLL) stock trades at $27.13 with a market capitalization of $1.04B. The stock is valued at a negative price-to-earnings (P/E) ratio of -13.46, reflecting a net loss over the last twelve months, price-to-book of 7.02, price-to-sales of 8.82. Over the past 52 weeks the stock has ranged between $10.85 and $27.89, and currently trades 2.7% below its 52-week high.
On profitability, CeriBell, Inc. generates a return on equity (ROE) of -44.85% (negative, reflecting a net loss), return on capital employed of -46.91%, an operating margin of -65.17%, a net profit margin of -64.73%.
CeriBell, Inc. by the numbers, 2022–2025
Between 2022 and 2025 CeriBell, Inc. reported revenue of $26.0M rising to $89.0M, a change of +242.3% across 4 years. Compounded, revenue has grown —% a year over five years, 50.7% over three, 36.9% over the last twelve months. Net profit fell to $-53.0M.
Operating margin went from -139.0% in 2022 to -65.6% in 2025, a gain of 73.4 percentage points. The most recent net margin is -64.73%. On a trailing twelve-month basis to Jun '26, revenue is $102.0M and net profit $-66.0M.
Borrowings rose from $18.0M to $22.0M, cash from operations was $-41.0M in the latest year, positive in 0 of the last 4.
Return on equity has averaged 3.5% over five years, and was -34.2% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
CeriBell, Inc. (CBLL) — frequently asked questions
What is CeriBell, Inc. (CBLL) stock price today?
CeriBell, Inc. (CBLL) is currently trading at $27.13, down 0.99% today.
What is CBLL P/E ratio?
CeriBell, Inc.'s P/E ratio is -13.46. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is CBLL return on equity (ROE)?
CeriBell, Inc.'s return on equity (ROE) is -44.85%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is CeriBell, Inc.'s market cap?
CeriBell, Inc. has a market capitalization of $1.04B.
Does CBLL pay a dividend?
CeriBell, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does CBLL carry?
CeriBell, Inc. has a debt-to-equity ratio of 0.17. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is CBLL's profit margin?
CeriBell, Inc. reports a net profit margin of -64.73% — the share of revenue left after every cost, including tax and interest.
What sector is CBLL in?
CeriBell, Inc. is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is CBLL listed on?
CeriBell, Inc. trades on — under the ticker CBLL.
What is CBLL's 52-week range?
Over the last year CeriBell, Inc. has traded between $10.85 and $27.89.
Related Healthcare Stocks
Popular Stocks
Screens CBLL currently matches
On the figures above, CeriBell, Inc. passes the filters for 6 of our ready-made screens, among them Low Debt Stocks, Small Cap Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.